Drug Shortage Report for ACT CLARITHROMYCIN XL
Report ID | 119901 |
Drug Identification Number | 02403196 |
Brand name | ACT CLARITHROMYCIN XL |
Common or Proper name | CLARITHROMYC FC TABLETS 500MG |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CLARITHROMYCIN |
Strength(s) | 500MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-07-08 |
Estimated end date | Unknown |
Actual end date | 2023-04-27 |
Shortage status | Resolved |
Updated date | 2023-04-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v19 | 2023-04-28 | English | Compare |
v18 | 2023-04-27 | French | Compare |
v17 | 2023-04-27 | English | Compare |
v16 | 2022-03-17 | French | Compare |
v15 | 2022-03-17 | English | Compare |
v14 | 2021-06-30 | French | Compare |
v13 | 2021-06-30 | English | Compare |
v12 | 2021-06-17 | French | Compare |
v11 | 2021-06-17 | English | Compare |
v10 | 2021-01-14 | French | Compare |
v9 | 2021-01-14 | English | Compare |
v8 | 2021-01-07 | French | Compare |
v7 | 2021-01-07 | English | Compare |
v6 | 2020-08-13 | French | Compare |
v5 | 2020-08-13 | English | Compare |
v4 | 2020-07-16 | French | Compare |
v3 | 2020-07-16 | English | Compare |
v2 | 2020-07-09 | French | Compare |
v1 | 2020-07-09 | English | Compare |
Showing 1 to 19 of 19